DCF — NORTH BALDWIN INFIRMARY
Enterprise Value: $-35.4M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-35.4M
Enterprise Value
$-12.4M
PV of Cash Flows
$-23.0M
PV of Terminal Value
$-37.1M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $57.0M | $-1.6M | -3.0% | $-4.0M | $-3.6M |
| Year 2 | $58.7M | $-1.0M | -2.0% | $-3.5M | $-2.9M |
| Year 3 | $60.4M | $-0.5M | -1.0% | $-3.0M | $-2.3M |
| Year 4 | $62.3M | $-0.2M | -0.0% | $-2.8M | $-1.9M |
| Year 5 | $64.1M | $-0.0M | -0.0% | $-2.7M | $-1.7M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-35.4M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$55.3M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.03252145071612374
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5